What is it about?

The letter cautions that the fMRI brain scan study used overly lenient statistics, which exaggerate results, and that drug-related blood flow changes could distort the fMRI signal, making interpretations uncertain and possibly misleading.

Featured Image

Why is it important?

fMRI depends on the BOLD signal, which is strongly influenced by cerebral blood flow (CBF). If escitalopram reduces CBF and psilocybin increases it, differences in BOLD responses—such as to emotional stimuli—may reflect vascular changes rather than true neural responses. This risks misinterpreting drug effects on the brain. Additionally, overly lenient statistical thresholds can inflate false positives and exaggerate findings, undermining the reliability of conclusions.

Perspectives

Hopefully, this letter will encourage future studies on how medications affect brain activity to use stricter statistics and account for drug effects on blood flow when interpreting fMRI results. This is essential to ensure findings truly reflect brain function, not vascular changes or inflated false positives—critical for advancing our understanding of psychiatric medications and, ultimately, psychiatric conditions.

Laust Vind Knudsen
Syddansk Universitet

Read the Original

This page is a summary of: Thresholding and Perfusion Considerations in Interpreting Reduced Brain Responsiveness With Escitalopram, American Journal of Psychiatry, January 2026, American Psychiatric Association,
DOI: 10.1176/appi.ajp.20250735.
You can read the full text:

Read

Contributors

The following have contributed to this page